These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 20214175

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S, Gold M, Nasir A, Vamvakias G.
    J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
    [Abstract] [Full Text] [Related]

  • 3. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD, Potts A, Alió Saenz AB, W0265-306 Study Group.
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and safety results of two topical combination acne regimens.
    Kircik LH.
    J Drugs Dermatol; 2009 Jul; 8(7):624-30. PubMed ID: 19588638
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE.
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [Abstract] [Full Text] [Related]

  • 12. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A, Chu A, Goulden V, Ambroziak M.
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
    Callender VD.
    J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
    Goreshi R, Samrao A, Ehst BD.
    J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
    Tanghetti E, Kircik L, Wilson D, Dhawan S.
    J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
    [Abstract] [Full Text] [Related]

  • 20. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N, West F, Finlay AY.
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.